We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.6B
AUM Growth
+$769M
(+16%)
Cap. Flow
+$469M
Cap. Flow
% of AUM
8.38%
Top 10 Holdings %
Top 10 Hldgs %
13.16%
Holding
1,266
New
125
Increased
352
Reduced
429
Closed
264
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$58.9M |
| 2 |
EOG Resources
EOG
|
+$37.7M |
| 3 |
Yum! Brands
YUM
|
+$29.2M |
| 4 |
Agilent Technologies
A
|
+$25.5M |
| 5 |
Occidental Petroleum
OXY
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$27.1M |
| 2 |
Intercontinental Exchange
ICE
|
+$26M |
| 3 |
Global Payments
GPN
|
+$24.2M |
| 4 |
Cadence Design Systems
CDNS
|
+$22.8M |
| 5 |
Apple
AAPL
|
+$22.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.55% |
| 2 | Financials | 15.15% |
| 3 | Healthcare | 14.96% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Industrials | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NUVA
751
DELISTED
NuVasive, Inc.
NUVA
| $405K | 0.01% |
6,080
| – | – |
|
752
Varonis Systems
VRNS
$5.25B
| $401K | 0.01% |
39,930
+3,720
| +10% | +$34K |
|
|
CRCM
753
DELISTED
CARE.COM, INC.
CRCM
| $399K | 0.01% |
40,058
+12,603
| +46% | +$135K |
|
754
AngioDynamics
ANGO
$562M
| $389K | 0.01% |
22,200
-1,300
| -6% | -$21.1K |
|
755
Fate Therapeutics
FATE
$281M
| $388K | 0.01% |
124,472
-54,175
| -30% | -$131K |
|
756
Karyopharm Therapeutics
KPTI
$168M
| $388K | 0.01% |
2,660
+240
| +10% | +$28.8K |
|
|
TNAV
757
DELISTED
Telenav Inc.
TNAV
| $388K | 0.01% |
67,749
-3,000
| -4% | -$16.3K |
|
|
DTLK
758
DELISTED
Datalink Corp
DTLK
| $387K | 0.01% |
36,508
+3,800
| +12% | +$36K |
|
759
Verastem
VSTM
$532M
| $386K | 0.01% |
24,163
-942
| -4% | -$15.2K |
|
760
Dawson Geophysical
DWSN
$155M
| $382K | 0.01% |
52,509
-1,785
| -3% | -$12.7K |
|
|
SEAC
761
DELISTED
Seachange International Inc
SEAC
| $382K | 0.01% |
6,390
-545
| -8% | -$33.9K |
|
|
CALY
762
Callaway Golf Company
CALY
$3.26B
| $378K | 0.01% |
+32,600
| New | +$364K |
|
763
Box
BOX
$4.02B
| $372K | 0.01% |
+23,600
| New | +$299K |
|
|
HDNG
764
DELISTED
Hardinge Inc
HDNG
| $371K | 0.01% |
33,315
-2,400
| -7% | -$25.2K |
|
|
SNMX
765
DELISTED
Senomyx, Inc.
SNMX
| $370K | 0.01% |
86,882
+36,911
| +74% | +$134K |
|
766
Standard BioTools
LAB
$326M
| $368K | 0.01% |
46,000
| – | – |
|
767
Strategic Education
STRA
$1.71B
| $366K | 0.01% |
7,830
| – | – |
|
768
Columbia Sportswear
COLM
$3.19B
| $363K | 0.01% |
6,390
| – | – |
|
|
SHLM
769
DELISTED
Schulman (A.) Inc
SHLM
| $362K | 0.01% |
+12,420
| New | +$335K |
|
|
FNHC
770
DELISTED
FedNat Holding Company Common Stock
FNHC
| $361K | 0.01% |
19,300
+1,800
| +10% | +$34.2K |
|
771
Clorox
CLX
$11.6B
| $360K | 0.01% |
2,879
-630
| -18% | -$82.5K |
|
|
FLXN
772
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $360K | 0.01% |
18,400
-10,400
| -36% | -$176K |
|
|
AHT
773
Ashford Hospitality Trust
AHT
$21M
| $358K | 0.01% |
62
+4
| +7% | +$24.5K |
|
|
MNTA
774
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $357K | 0.01% |
30,500
-37,500
| -55% | -$441K |
|
|
KEM
775
DELISTED
KEMET Corporation
KEM
| $357K | 0.01% |
100,002
-24,249
| -20% | -$81.1K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2016 Portfolio in Review
As of Q3 2016, Jacobs Levy Equity Management held 1,266 positions worth $5.6B, up 16% from $4.83B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management deployed $469M of net new capital in Q3 2016, opening 125 new positions and adding to 352 existing holdings. Its largest new stake was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Intercontinental Exchange, an estimated $26M trimmed.
- Jacobs Levy Equity Management's largest Q3 2016 buy was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
- Jacobs Levy Equity Management added most to Agilent Technologies in Q3 2016, an estimated $25.5M increase.
- Jacobs Levy Equity Management's biggest Q3 2016 reduction was Intercontinental Exchange, cutting an estimated $26M.
- Jacobs Levy Equity Management fully exited Gen Digital in Q3 2016, selling an estimated $27.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $5.6B portfolio in Q3 2016.
- Jacobs Levy Equity Management opened 125 new positions and closed 264 in Q3 2016.
- Jacobs Levy Equity Management's portfolio value rose 16% quarter-over-quarter to $5.6B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2016, filed 14 Nov 2016.